Swiss National Bank
TECX

Swiss National Bank’s Tectonic Therapeutic TECX Stock Holding History

Swiss National Bank’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,675
Closed -$447K – 2754
2021
Q3 		$447K Hold
6,675
– – ﹤0.01% 2593
2021
Q2 		$712K Hold
6,675
– – ﹤0.01% 2576
2021
Q1 		$1.02M Hold
6,675
– – ﹤0.01% 2339
2020
Q4 		$1.12M Buy
6,675
+1,567
+31% +$279K ﹤0.01% 2242
2020
Q3 		$798K Buy
5,108
+83
+2% +$16.7K ﹤0.01% 2212
2020
Q2 		$1.05M Buy
5,025
+658
+15% +$136K ﹤0.01% 2073
2020
Q1 		$815K Buy
4,367
+834
+24% +$196K ﹤0.01% 1947
2019
Q4 		$854K Buy
3,533
+233
+7% +$44.9K ﹤0.01% 2226
2019
Q3 		$559K Buy
3,300
+1,817
+123% +$411K ﹤0.01% 2328
2019
Q2 		$289K Sell
1,483
-517
-26% -$111K ﹤0.01% 2520
2019
Q1 		$529K Buy
2,000
+1,117
+127% +$204K ﹤0.01% 2358
2018
Q4 		$176K Buy
+883
New +$269K ﹤0.01% 2523

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Swiss National Bank's TECX Position: Q4 2021 in Review

Swiss National Bank sold out of Tectonic Therapeutic (TECX) in Q4 2021, closing a stake of 6,675 shares — an estimated $447K sold.

Swiss National Bank first reported a position in TECX in Q4 2018 and held it in 12 quarters. The position peaked at $1.12M in Q4 2020. 93 funds tracked by Wall St. Rank hold TECX as of Q4 2021.

  • Swiss National Bank reported no remaining Tectonic Therapeutic position as of Q4 2021 after selling out during the quarter.
  • Swiss National Bank sold 6,675 Tectonic Therapeutic shares in Q4 2021, an estimated $447K.
  • Swiss National Bank first reported a position in Tectonic Therapeutic in Q4 2018 and held it in 12 quarters.
  • Swiss National Bank's Tectonic Therapeutic position peaked at $1.12M in Q4 2020.
  • 93 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2021.

Based on Swiss National Bank's 13F filing for Q4 2021, filed 8 Feb 2022.